Management of bacterial infections in haematological patients.
D000208:Acute Disease; D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000627:therapeutic use; D004338:Drug Combinations; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000150:complications*; D007945:Leukemia, Lymphoid / Q000150:complications; D008223:Lymphoma / Q000150:complications*; D009101:Multiple Myeloma / Q000150:complications; D009503:Neutropenia / Q000150:complications; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004338:Drug Combinations; D010406:Penicillins; D011113:Polymyxins